Press releases
- Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance
- Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference
- Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024
- Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System
- Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance
- Paragon 28 to Present at the CG 2024 Musculoskeletal Conference
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.50 |
---|---|
High | 7.50 |
Low | 7.50 |
Bid | 7.35 |
Offer | 7.50 |
Previous close | 8.70 |
Average volume | 0.00 |
---|---|
Shares outstanding | 82.91m |
Free float | 49.83m |
P/E (TTM) | -- |
Market cap | 683.98m USD |
EPS (TTM) | -0.5819 USD |
Data delayed at least 15 minutes, as of May 10 2024 07:13 BST.
More ▼